Published in Surgery on February 01, 1998
Combined cardiothoracic surgery and interventions of the para/thyroid gland. A rare clinical cooperation. Z Kardiol (2005) 0.81
Cost-effectiveness analysis in surgery: who will use it and how? Surgery (1998) 0.75
Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA (1998) 3.19
Patient preferences for location of care: implications for regionalization. Med Care (1999) 2.57
Potential reduction in mortality rates using an intensivist model to manage intensive care units. Eff Clin Pract (2001) 2.35
Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Ann Intern Med (1999) 2.15
Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med (1994) 2.10
Operative mortality with elective surgery in older adults. Eff Clin Pract (2001) 2.06
The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96
Case mix, quality and high-cost kidney transplant patients. Am J Transplant (2009) 1.79
Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg (2000) 1.78
The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med (1999) 1.73
Safety of the blood supply in the United States: opportunities and controversies. Ann Intern Med (1997) 1.71
Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply. JAMA (1994) 1.67
The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol (2000) 1.60
Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion (1995) 1.59
Cardiologists performing peripheral angioplasties: impact on utilization. Eff Clin Pract (2001) 1.56
A prospective study comparing the complication rates between laparoscopic and open ventral hernia repairs. Surg Endosc (2003) 1.49
Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest (1995) 1.45
The effects of donor and recipient practices on transplant center finances. Am J Transplant (2008) 1.44
Cost-effectiveness of surgery for small abdominal aortic aneurysms on the basis of data from the United Kingdom small aneurysm trial. J Vasc Surg (2000) 1.38
Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation (1996) 1.33
Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg (1998) 1.28
Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg (2000) 1.27
National trends in utilization and outcomes of antireflux surgery. Surg Endosc (2003) 1.18
Cost-effectiveness of carotid endarterectomy in asymptomatic patients. J Vasc Surg (1997) 1.14
Variation in the use of laparoscopic cholecystectomy for elderly patients with acute cholecystitis. Arch Surg (2000) 1.13
Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion (1997) 1.09
Laparoscopy may be lowering the threshold to operate on patients with suspected appendicitis. Surg Endosc (2002) 1.08
High-risk surgery--follow the crowd. JAMA (2000) 1.08
Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg (1998) 1.05
Should endovascular surgery lower the threshold for repair of abdominal aortic aneurysms? J Vasc Surg (1999) 1.01
The Dartmouth Atlas of Vascular Health Care. Cardiovasc Surg (2000) 1.00
Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis. Circulation (1999) 0.95
Efficacy versus effectiveness of carotid endarterectomy. Eff Clin Pract (1999) 0.89
Trends in the use of radical prostatectomy for treatment of prostate cancer. Eff Clin Pract (1999) 0.88
Changes in patients undergoing coronary artery bypass grafting: 1987-1990. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg (1994) 0.88
Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group. Transfusion (1997) 0.86
Relation of surgical volume to outcome. Ann Surg (2000) 0.86
Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology (1994) 0.85
Pounds of prevention for ounces of cure: surgery as a preventive strategy. Lancet (1999) 0.85
Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med (1993) 0.84
Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Con. Transfusion (1994) 0.82
Trends in rates of reexploration for hemorrhage after coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg (1999) 0.80
Update of cost-effectiveness analysis for solvent-detergent-treated plasma. JAMA (1999) 0.77
The learning curve for laparoscopic colorectal surgery. Arch Surg (1997) 0.75
Outcomes in vascular surgery: volume versus certification. Surgery (2001) 0.75
Estimates of risk of posttransfusion hepatitis. Am J Med (1992) 0.75
Misuse of multivariate analysis. Surgery (1998) 0.75
Risk of breast cancer in carriers of BRCA gene mutations. N Engl J Med (1997) 0.75
Should physicians screen for mild thyroid failure? JAMA (1996) 0.75
The Björk-Shiley dilemma. Ann Thorac Surg (1993) 0.75
Use of inferior vena cava filters in the Medicare population. Ann Vasc Surg (1995) 0.75
Decision analysis for small, asymptomatic intracranial arteriovenous malformations. Neurosurg Focus (2001) 0.75